Cabozantinib plus atezolizumab in metastatic prostate cancer (CONTACT-02): final analyses from a phase 3, open-label, randomised trial

Neeraj Agarwal, Arun Azad, Joan Carles, Nobuaki Matsubara, Stéphane Oudard, Fred Saad, Axel S. Merseburger, Andrey Soares, Bradley A. McGregor, Bogdan Żurawski, Marinos Tsiatas, Scott North, Igor Bondarenko, Margarita Alfie, Evangelos Bournakis, Lorenzo Antonuzzo, Lena Evilevitch, Andrew D. Simmons, Fong Wang, Roberta Ferraldeschi, Prachi Nandoskar, Sumanta K. Pal